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ABSTRACT
Polyadenylation of eukaryotic mRNAs contributes to
stability, transport and translation, and is catalyzed
by a large complex of conserved proteins. The Pcf11
subunit of the yeast CF IA factor functions as a
scaffold for the processing machinery during the
termination and polyadenylation of transcripts.
Its partner, Clp1, is needed for mRNA processing,
but its precise molecular role has remained enig-
matic. We show that Clp1 interacts with the
Cleavage–Polyadenylation Factor (CPF) through its
N-terminal and central domains, and thus provides
cross-factor connections within the processing
complex. Clp1 is known to bind ATP, consistent
with the reported RNA kinase activity of human
Clp1. However, substitution of conserved amino
acids in the ATP-binding site did not affect cell
growth, suggesting that the essential function of
yeast Clp1 does not involve ATP hydrolysis.
Surprisingly, non-viable mutations predicted to
displace ATP did not affect ATP binding but dis-
turbed the Clp1–Pcf11 interaction. In support of
the importance of this interaction, a mutation in
Pcf11 that disrupts the Clp1 contact caused
defects in growth, 30-end processing and tran-
scription termination. These results define Clp1
as a bridge between CF IA and CPF and indicate
that the Clp1–Pcf11 interaction is modulated by
amino acids in the conserved ATP-binding site
of Clp1.
INTRODUCTION
Poly(A) tails are added post-transcriptionally to nuclear
pre-mRNA 30-ends in eukaryotic cells in a two-step
reaction involving cleavage in the 30-untranslated region
and extension of the new 30-end by poly(A) synthesis (1,2).
Polyadenylation helps the mRNA function efﬁciently in
protein synthesis and prevents its premature degradation
before it has performed this task. Besides being an essen-
tial step in mRNA maturation, it is also a point at which
the cell controls gene expression (2–4). Inappropriate
30-end processing can contribute to human diseases (5),
and modulate the expression of oncogenes (6). Poly-
adenylation factors are also targeted by some viruses to
limit expression of host cell mRNAs and favor viral
protein production (7–10).
The complex that catalyzes this processing is well
conserved from yeast to humans, although the individual
subunits separate into somewhat different subcomplexes
upon biochemical puriﬁcation (1,2). In Sachharomyces
cerevisiae, cleavage requires the 4-subunit Cleavage–
polyadenylation Factor IA (CF IA), the 15-subunit
Cleavage–Polyadenylation Factor (CPF) and Hrp1–
Nab4, while tail synthesis requires these factors plus the
Pab1 and Nab2 poly(A)-binding proteins, which restrict
tail length (11,12). CPF recognizes sequences around the
poly(A) site and contains the poly(A) polymerase Pap1
and the Ysh1 nuclease, which are the enzymatic activities
that act at the cleavage site, while CF IA and Hrp1 help
position CPF at the poly(A) site. These factors are also
necessary to insure that RNA Polymerase II transcription
terminates in a timely fashion and does not interfere with
the function of downstream DNA elements such as pro-
moters, centromeres and origins of replication or lead to
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silencing (13). A current challenge in the area of mRNA
30-end processing is to improve our understanding of how
the architecture of the cleavage–polyadenylation complex
contributes to function and to integration of this process-
ing machinery with other nuclear events.
In this regard, the essential Pcf11 component of CF IA
is one of the better-studied subunits, and is required for
both the cleavage and poly(A) addition steps. It is the only
subunit of CF IA that contacts each of the other three
subunits—Rna14, Rna15 and Clp1 (13–16), and it is
thought to be one of the scaffold proteins of the process-
ing complex. In support of such a role, Pcf11 also interacts
with the Pta1 and Ssu72 subunits of CPF (17–19) and with
the phosphorylated C-terminal domain (CTD) of the
Rpb1 subunit of RNAP II (20,21), thus connecting the
processing machinery to the transcription elongation
complex. These interactions are mediated through
a CTD interaction domain (CID) at its N-terminus, a
central domain for Rna14–Rna15 interaction, and a
C-terminal Clp1 interaction domain (Figure 1A).
Mutations in the CID impair efﬁcient termination of
snoRNA and short mRNA transcripts, while mutation
elsewhere affects the 30-end processing and termination
of long mRNAs (13–16).
Like Pcf11, the Rna14 and Rna15 subunits of CF IA
are also required for 30-end processing and termination.
Rna15 recognizes the A-rich processing signal located
upstream of the poly(A) site (22) and contact between its
RNA Recognition Motif (RRM) and that of Hrp1 at the
UA-rich signal is induced upon RNA binding (23). The
tight interaction of Rna15 with Rna14 increases its afﬁnity
for RNA (24,25), and an Rna14-mediated bridge to Hrp1
helps direct Rna15 to the correct binding site (22).
In contrast to other CF IA subunits, much less is known
about the precise function of yeast Clp1 other than being
required for both cleavage and poly(A) addition (26).
Discovered in 1997 by Minvielle-Sebastia et al. (27), it
interacts in pull-down experiments with Cft1, Cft2, Pta1
and Pcf11 (17,19,26). Surprisingly, Clp1 is the best
characterized CF IA subunit in terms of having the most
complete 3D structure. It contains a large central domain
that binds ATP and is ﬂanked by two smaller N- and
C-terminal domains (28). Part of the central domain
surface and a hydrophobic cleft formed by the central
and CTD create the Pcf11-binding site. The conserved
human Clp1, and an archeal homolog, but not yeast
Clp1, are 50-OH polynucleotide kinases, and this activity
in humans is important in tRNA splicing (28–32).
The goal of the work described here is to more com-
pletely deﬁne the role of Clp1 in the processing complex.
In this study, we identiﬁed new interactions between Clp1
and components of the processing machinery and found
that the N- and C-terminal domains of Clp1 are essential
for cell viability. In addition, speciﬁc mutations in the
ATP-binding site are lethal, and surprisingly, interfere
with Pcf11 interaction. Mutations in Pcf11 that perturb
Clp1 binding cause temperature-sensitive growth and
affect cleavage, polyadenylation and transcription
termination.
MATERIALS AND METHODS
Yeast strains and culture
The S. cerevisiae strains used in this study are as follows.
Strain CM246 (MATaMhis3D1 leu2D1 lys2D0 ura3D0
clp1::KanMX4 [YCpLac33-CLP1]) was constructed by
transforming a diploid strain with a chromosomal copy
of CLP1 disrupted with KanMX4 module (clp1::KanMX)
with a YCpURA3-CLP1 plasmid, and then sporulating to
create the haploid strain. The PCF11 (NA53), pcf11-9
(NA67) and pJ69-4A strains were described previously
(15,33,34). To determine the effect of clp1 and pcf11 mu-
tations on yeast cell growth, the plasmid shufﬂe comple-
mentation assay was used (35). The pRS315 plasmids
containing clp1 mutations were analyzed in the CLP1
plasmid shufﬂe strain CM246, and the pRS315 plasmids
containing pcf11 mutations were analyzed in the PCf11
plasmid shufﬂe strain NA53. Growth properties were
analyzed by growing the strains in liquid YPD at room
temperature to an optical density at 600nm of 1.0,
spotting 5ml of 10-fold serial dilutions on YPD plates
and incubating the plates for 3 days at 16, 24, 30, 37 or
39 C.
Saccharomyces cerevisiae CLP1 and PCF11 plasmids
and mutants
CLP1 plasmids. For YCpLac33-clp1, the coding sequence
of CLP1 was ampliﬁed from genomic DNA by PCR. The
PCR product was digested with NdeI and XhoI, and
cloned into the YCpLac33 (URA3) vector ﬂanked by the
800-bp upstream and downstream of the coding region of
the Yth1 gene. pRS315-CLP1 and its truncations were
constructed by PCR from YCpLac33-clp1 and cloned by
NheI and NcoI into pRS315 (LEU2). The CLP1 sequence
is ﬂanked by a Myc epitope tag at the N-terminus and a
V5 tag at the C-terminus and under the control of the
MPEI promoter and terminator sequences (900-bp
upstream and downstream of the coding region of the
MPE1 gene). Glutathione S-transferase (GST) fusion
Clp1 and its truncations were constructed by insertion of
PCR-ampliﬁed fragments into the EcoRI and NotI of
pGEX-6 P-2. For yeast two hybrid analyses, the CLP1
coding sequence was cloned in pGAD-C2 using EcoRI
and Pst1.
Pcf11 plasmids. pFL38-pcf11 and pcf11-pGBDU-C1 were
described previously (15,33,34,36). pRS315-pcf11 was
constructed by PCR of the coding region of PCF11 gene
from genomic DNA and cloned by NheI and NcoI into
pRS315-Clp1 digested with the same enzymes.
Clp1 and Pcf11 site - directed mutants. Plasmids contain-
ing site-directed amino acid substitutions in Clp1 or Pcf11
were constructed using the QuikChange Mutagenesis Kit
(Stratagene). All DNA fragments generated by PCR amp-
liﬁcation in this study were veriﬁed by DNA sequencing.
Western blot analyses and immunoprecipitations
The steady-state levels of speciﬁc proteins were
determined by western blot using cells grown to
Nucleic Acids Research,2012, Vol.40, No. 3 1215mid-exponential phase in liquid media and extracts
prepared as described previously (37). Extracts (50mgo f
protein) were resolved on an SDS–10% polyacrylamide
gel, and proteins were transferred to Immobilon-P
polyvinylidene diﬂuoride membrane (Millipore).
Monoclonal antibody against Pta1 was described previ-
ously (38). Anti-V5 antibody was obtained from
Invitrogen, Glutathione S-transferase (GST) antibody
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Figure 1. Functional analysis of Clp1 domains. (A) Schematic of mutations analyzed in this study. The linear representation of Pcf11 indicates the
CID, the Q-rich domain (Q20), the regions which interact with Rna14, Rna15 and Clp1, the two regions containing zinc ﬁngers (ZF), and the pos-
itions of the R480A and W482A mutations. The Clp1 representation shows the three domains determined by structural analysis (28), the N-terminal
and C-terminal deletions, and the positions of mutations in the Pcf11 interaction interface and the ATP-binding site. (B) The amino and carboxyl
termini of Clp1 are essential for cell viability. The CM246 [YCpURA3-CLP1] plasmid shufﬂe strain expressing epitope-tagged versions of wild-type
Clp1 or the indicated deletion derivatives on a LEU2-marked plasmid were streaked on 5-FOA medium to counterselect the YCpURA3-CLP1
plasmid. Plates were photographed following incubation for 4 days at 24 C. (C) In vivo expression of truncated forms of Clp1. Extracts prepared
from strains expressing either full-length Clp1 or the indicated deletion derivatives and grown on selective medium were analyzed by western blot
using monoclonal antibody against the V5 tag on Clp1 or the CPF subunit Pta1 as a loading control. Asterisk indicates non-speciﬁc band detected by
the V5 antibody. (D) Clp1 interacts with speciﬁc CPF subunits.
35S-labeled in vitro-translated subunits of CPF were incubated with GST, GST-Clp1,
GST-clp1(101–445) or GST-clp1(1–341) bound to glutathione–Sepharose beads. The bound proteins and 10% of the input were separated on a 10%
polyacrylamide–SDS gel and detected by autoradiography.
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and GAL4-TA (SC-1663) antibodies from Santa Cruz
Biotechnology. Immunoprecipitations from yeast extract
were performed as described by Zhelkovsky et al. (39).
Yeast two-hybrid analysis
pGAD-C2 vector expressing the Gal4 activation domain
fused to wild-type Clp1 were transformed into the
PJ69-4A host strain. The resulting strains were trans-
formed with the pGBDU-C2 vector expressing the Gal4
DNA-binding domain fused to wild-type and mutant
Pcf11. Transformants were selected on complete medium
lacking uracil and leucine (CM–UL). Protein–protein
interactions were scored by the ability of cells to grow
on complete medium lacking uracil, leucine and histidine
(CM-ULH) as described (17).
Recombinant proteins and in vitro protein–protein
interaction assays
Radiolabeled proteins used in this study were generated
in vitro with the TNT rabbit reticulocyte lysate system
(Promega) in the presence of [
35S]-methionine in a total
volume of 50ml. Expression and puriﬁcation of recombin-
ant GST-tagged proteins from the Escherichia coli Rosetta
(DE3), as well as in vitro binding experiments were carried
out as described previously (17,26). To produce recombin-
ant CF IA, Rna14 and Rna15 were co-expressed from a
pETDuet vector as described previously (24). Clp1 and
Pcf11 were cloned into and then co-expressed from a
pRSFDuet vector (Novagen). Pcf11 was cloned into the
site 1 position within the vector using BamH1 and Not1
restriction enzymes. Clp1 was cloned into the second
position using Nde1 and Kpn1 restriction sites. Protein
expression in E. coli strain BL21 (DE3) pLysS was
induced with 0.2mM isopropyl 1-thio-b-D-galacto-
pyranoside (IPTG) overnight at 16 C. Harvested cells
were lysed in Tris–HCl, pH 8.0, 250mM NaCl, 5%
glycerol, 5mM bME, 5mM PMSF using the Avestin C5
homogenizer and debris removed by centrifugation at
30000g. The CF IA complex was puriﬁed using a combin-
ation of Ni-NTA, ion exchange chromatography and size
exclusion chromatography. A detailed characterization of
the CF IA complex will be presented elsewhere (J.
Gordon, S. Shikov, J. Kuehner, M. Liriano, E. Lee, W.
Stafford, C. Moore and A. Bohm, submitted for
publication).
In vitro and in vivo RNA analyses
Preparation of yeast cell extracts, transcription of [a-
32P]
UTP-labeled full-length GAL7-1 RNA or precleaved
GAL7-9 RNA and processing assays have been described
previously (17,38).
b-Galactosidase assay
Wild-type and mutant strains were transformed with
various reporter vectors [pHZ182, no poly(A) site;
pL101, ADH2 poly(A) site; pL501, GAL7 poly(A) site]
(40). Cells were grown in synthetic medium lacking
uracil but containing 2% galactose to an OD600 of 0.2
and assayed by using the Gal-Screen System (Applied
Biosystems).
Chromatin immunoprecipitation
Cross-linking, isolation of chromatin and sonication were
performed as described previously (41). WT and mutant
strains were grown to midlog (OD=0.7–0.9) at 30 C,
harvested, resuspended in prewarmed growth medium
(30 Co r3 9  C), then incubated at either 30 Co r3 9  C
for an additional 60min. The PCR was performed using
2ml of immunoprecipitated DNA or 0.4ml of input DNA
and the appropriate primer pairs. PMA1 primer pairs
were described previously (42). PCR products were
resolved in a 1.5% agarose gel and visualized by
ethidium bromide staining using an AlphaImager 2000.
Rpb3 occupancy of each of the indicated regions of
PMA1 was calculated as a sample IP:input ratio and
normalized to the sample IP:input ratio of an untrans-
cribed region of chromosome V. Serial dilutions of chro-
matin from samples not subject to immunoprecipitation
were used to demonstrate that samples are analyzed in the
linear range.
ATP-binding assays
The ATP resin-binding assay was based on the protocol of
Haystead, et al. (43). g-Aminophenyl-adenosine triphos-
phate immobilized on agarose (Jena Biosciences) was
equilibrated in reaction buffer (40mM Tris, pH 8.0,
1mM MgCl2, 0.1% b-mercaptoethanol, 0.1% NP40,
150mM NaCl). An amount of 500ml of protein (10mM)
was incubated with 100ml of resin at 4 C for 1h. The resin
was washed four times with 500ml of reaction buffer and
eluted with 500ml of reaction buffer+20mM ATP.
The ATP content of Clp1 was determined using a modi-
ﬁcation of the protocol described by Noble et al. (28).
Equal amounts of recombinant protein were precipitated
by addition of trichloroacetic acid (TCA) to 20% and the
supernatant containing the released nucleotide removed
and neutralized by addition of 175mM sodium acetate
(pH 8.0). Extracted nucleotides were applied to a DNA
Pac PA-100 (Dionex) HPLC column equilibrated in
10mM Tris buffer, pH 8.0. The column retention time
of the nucleotide after applying a gradient of 0–1M
NaCl over 30min was measured by monitoring the
column eluent at 260nm. Under these conditions, a
control ATP sample eluted at 0.57M NaCl.
RESULTS
Clp1 interacts with CPF subunits
The crystal structure of Clp1 with bound ATP (28) sug-
gested that the region formed by the ﬁrst 100 amino acids
of Clp1 may act as a lid to cover the ATP-binding pocket
of the central domain, while the C-terminal region (amino
acids 341–445) contributes to Pcf11 binding (Figure 1A).
To better understand the role of the Clp1 N- and
C-termini, we tested the effect of deleting these domains
on cell growth, using the plasmid shufﬂe assay. Mutants
lacking the N-terminal domain (clp1-DN), or the
Nucleic Acids Research,2012, Vol.40, No. 3 1217C-terminal (clp1-DC) amino acids were not viable when
the wild-type CLP1 plasmid was counter selected on
5-FOA medium (Figure 1B). Western blot analysis con-
ﬁrmed that the mutant Clp1 proteins were expressed,
albeit at a reduced level for clp1-N (Figure 1C). These
results indicate an essential role for the N- and the
C-termini in Clp1 function.
To further understand how Clp1 works in mRNA
30-end formation, we next asked if Clp1 interacts directly
with any of the CPF subunits. By using a GST–Clp1
fusion protein in pull-down assays, we detected clear inter-
actions with CPF components Cft1, Pta1, Pfs2, Ysh1 and
Ssu72, and no interaction with Yth1, Mpe1, Pap1, Cft2
and Fip1 (Figure 1D). Using the same assay, we found the
N-terminal region of Clp1 is required for Ysh1 and Ssu72
interaction and the central region is required for Cft1,
Pta1 and Pfs2 interactions (Figure 1D). This analysis
suggests that Clp1 provides cross-factor connections to
several CPF subunits.
Weakening the Pcf11–Clp1 interaction causes a
thermosensitive growth phenotype
Based on the structure of the Clp1–Pcf11 complex (28), we
made several mutations in Clp1 and Pcf11 that could
disrupt interaction of the two proteins. Three substitutions
(S179E, S192R and R236A) were selected on the Clp1 side
of the interaction interface and introduced individually
into the Clp1 coding sequence (Figure 1A). However,
strains carrying these mutants as the only forms of Clp1
grew as well as wild-type on rich medium at 16, 23, 30, 37
and 39 C. If indeed the Clp1–Pcf11 interaction is import-
ant for function of the processing complex, contacts with
Pcf11 through other amino acids that were not mutated
may be sufﬁcient to maintain the interaction.
There are two conserved residues in Pcf11 (R480 and
W482) that are extensively involved in hydrogen bonding
and hydrophobic interactions at the protein–protein inter-
face (28). Both side chains project into pockets formed on
the surface of Clp1. Site-directed mutagenesis was used to
replace both of these residues with alanine. This mutant
strain, pcf11(RW-A), grew like wild-type at 16, 24 and
30 C, but exhibited reduced growth at 37 C and no
growth at 39 C (Figure 2A). Western blot analysis con-
ﬁrmed that the growth phenotypes were not due to in-
stability of the mutant pcf11 protein (Figure 2B).
To more directly examine the cause of the thermo-
sensitive growth, we tested the ability of pcf11(RW-A)
Figure 2. The pcf11 (RW-A) mutant is thermosensitive for growth and
defective for Clp1 interaction. (A) Relative growth rates at different
temperatures. Strains were grown in liquid YPD, and 10-fold serial
dilutions were spotted on YPD plates and incubated for 2–3 days at
the indicated temperatures. (B) In vivo expression of the pcf11 (RW-A)
mutant. Cells containing a chromosomal deletion of the PCF11 gene
but expressing V5-tagged forms of either Pcf11 or pcf11 (RW-A) or an
untagged version of wild-type Pcf11 were grown at 30 C and then
shifted to either 30 Co r3 9  C for an additional 60min. Extracts
from these cells were analyzed by western blot using a monoclonal
antibody against the V5 tag or Pta1. (C) Two-hybrid analysis of the
interaction between pcf11(RW-A) and Clp1. For two-hybrid analysis in
yeast, plasmids carrying Pcf11, pcf11 (RW-A) fused to the Gal4
DNA-binding domain (GBD), or only the GBD (none) and plasmid
carrying Clp1 fused to the Gal4 activation domain (pGAD-Clp1) were
cotransformed into strain PJ69-4A. Ten-fold serial dilutions of the re-
sulting strains were spotted on medium lacking uracil and leucine
(CM-UL), as indicated. Activation of HIS3 expression was tested by
spotting the same strains on medium lacking uracil, leucine and histi-
dine (CM-ULH), and incubated for 2–3 days at 30 C. (D) Expression
of GBD-Pcf11 and GAD-Clp1 analyzed by western blot. Extracts
prepared from the different two-hybrid strains grown at 30 C were
analyzed by western blot using a monoclonal antibody recognizing
either the GAL4 activation or DNA-binding domain. (E) Pulldowns
of Pcf11/Clp1 complexes in yeast extract. Extract was prepared from
cells expressing V5-tagged forms of either Pcf11 or pcf11 (RW-A) and
grown at 30 C. Immunoprecipitations from each extract were con-
ducted using antibody against the V5 epitope, and blots of the
precipitated proteins (IP) probed with Clp1 or Pcf11 antibody. The
amount of Clp1 in the different extracts is shown in the panel
marked ‘Input’.
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Plasmids carrying the GAL4 DNA-binding domain fused
to PCF11 (pGBDU-Pcf11) and plasmids carrying the
GAL4 activation domain fused to CLP1 (pGAD-Clp1)
were cotransformed into the two-hybrid tester strain
PJ69-4A, and growth was examined at 30 C. All
transformants grew well on media that selected for both
plasmids, indicating that none of the fusion proteins
were dominant-negative (Figure 2C). In addition, the
GAD-Clp1 and GBDU-Pcf11 fusions could be detected
by western blot analysis using antibodies speciﬁc to
GAL4 binding and activation domains (Figure 2D).
Positive two-hybrid interactions activate transcription of
a HIS3 reporter gene and allow growth on medium
lacking histidine (CM-ULH). pGAD-Clp1 did not
promote growth in the presence of pGBDU vector
alone. When pGAD-Clp1 was tested for interaction with
the different pGBDU-Pcf11 constructs, we found that in
contrast to the wild-type Pcf11, pcf11(RW-A) did not
allow growth in the absence of histidine. These results
indicate that Pcf11 amino acids R480 and W482 are
needed for Clp1 interaction. The loss of a two-hybrid
interaction at 30 C but viability of the pcf11 mutant at
the same temperature suggests that other interactions
within the processing complex can compensate for a
weakened Pcf11–Clp1 interaction at the lower tempera-
ture. It is also possible that the GBD and GAD fusions
to Clp1 and Pcf11 interfere with such compensatory inter-
actions, thus heightening an interaction defect when
measured by two-hybrid analysis.
To further conﬁrm the weakened interaction between
Clp1 and the pcf11(RW-A) mutant protein, we performed
pull-down assays from yeast extracts. The amount of Clp1
found in extract is not affected by the pcf11 mutation
(Figure 2E). However, signiﬁcantly less Clp1 was
observed in complex with pcf11(RW-A) compared to
that associated with wild-type Pcf11.
Disruption of the Pcf11–Clp1 interaction causes defects in
mRNA 30-end processing and transcription termination
To more directly examine the cause of the thermosensitive
growth phenotype, we tested the functionality of the
pcf11(RW-A) allele using in vitro and in vivo assays for
30-end formation and transcription termination. Extracts
prepared from cells expressing pcf11(RW-A) grown at
30 C showed very little processing activity in a coupled
cleavage–polyadenylation assay when compared to extract
isolated from a wild-type strain (Figure 3A, left panel).
There was no accumulation of cleaved, unadenylated
product, indicating that the cleavage step was defective.
The mutant extract also exhibited much reduced activity
when poly(A) addition was assayed on a precleaved sub-
strate (Figure 3A, right panel). Both cleavage and
poly(A) addition in the pcf11(RW-A) extract could be
recovered by the addition of a recombinant CF IA
complex containing Pcf11, Clp1, Rna14 and Rna15
(Figure 3B), indicating that the function of the CPF
and Hrp1 processing factors were not affected by the
mutation in Pcf11.
To test whether the pcf11(RW-A) mutation affected
processing and transcription termination in vivo, we used
a previously described system in which a poly(A) site is
inserted into an intron upstream of the lacZ gene (40).
Cells expressing wild-type Pcf11 or pcf11(RW-A) were
transformed with reporter plasmids that had either the
30-end of the ADH2 or GAL7 genes inserted into the
intron, or as a control, one with no insertion, and levels
of b-galactosidase activity determined. As expected, in
wild-type cells, the presence of either poly(A) site
blocked read-through transcription into the lacZ gene
(Figure 4A). The pcf11 (RW-A) strain showed an
increase of 3-fold in the level of read-through transcription
compared to the wild-type for the ADH2 polyadenylation
signal and an even greater increase (20 ) for the GAL7
Figure 3. Mutations in the Clp1 interaction interface of Pcf11 cause defects in mRNA 30-end formation in vitro.( A) In vitro 30-end processing assay.
For coupled cleavage-polyadenylation assays (left side), extracts prepared from the strains containing the wild-type (PCF11) or the pcf11(RW-A)
mutant grown at 30 C were incubated with ATP and
32P-labeled full-length GAL7-1 RNA (Pre, unreacted precursor) for 20min at 30 C. The same
conditions were used for poly(A) addition assays (right side) except that the precleaved GAL7-9 RNA was used as precursor. Products were resolved
on a denaturing 5% polyacrylamide gel and visualized with a PhosphorImager. Positions of substrate and product are indicated on the left and right.
(B) The processing defect of pcf11(RW-A) is rescued by addition of CF IA. Coupled cleavage-polyadenylation assays were performed as described in
Panel A using the indicated extracts. Recombinant CF IA containing wild-type Clp1, Pcf11, Rna14 and Rna15 was added to pcf11(RW-A) extract
before initiating the reaction (right-most lane).
Nucleic Acids Research,2012, Vol.40, No. 3 1219poly(A) site (Figure 4A). For comparison, we used the
pcf11-9 allele, which has been previously shown to have
cleavage and transcription termination defects (14,15).
This mutation caused a greater read-through compared
to the pcf11(RW-A) mutation, with a 6  increase for
ADH2 and 68  for GAL7 (Figure 4A). It is not known
why termination driven by the GAL7 poly(A) site is more
sensitive to mutations in PCF11.
These results suggest that the defect in 30-end processing
observed with the pcf11(RW-A) mutant is also causing a
defect in termination. This conclusion was conﬁrmed by
determining the chromatin immunoprecipitation (ChIP)
proﬁle of RNA Polymerase II (RNAP II) across the
PMA1 gene (Figure 4B–D). In the pcf11 mutant strain
but not the wild-type, crosslinking of the RNAP II
subunit Rpb3 extended into position 9, which is located
downstream of the distal PMA1 poly(A) site. Together,
these analyses indicate that the Pcf11–Clp1 interaction is
important for efﬁcient 30-end processing and termination
of mRNA transcripts.
Speciﬁc alterations in the Clp1-ATP-binding site give a
non-functional protein
The central domain of yeast and human Clp1 possesses a
canonical P-loop (GxxxxGKT/S) which spans G130 to
T137 of yeast Clpl1, along with the switch regions char-
acteristic of the SIMIBI class of ATP/GTPases (44). To
probe the function of this region of Clp1, site-directed
mutagenesis was employed to introduce single or double
amino acid substitutions at residues in yeast Clp1 that
should affect the ATP binding either at the nitrogenous
base, the ribose or the phosphate (D33A, K72A, the
double mutant D33A-K72A and K136A) based on the
published structure (28). All of the mutants were viable
in the absence of wild-type Clp1, and when tested on rich
(YPD) medium at 16, 23, 30, 37 and 39 C, all of these clp1
mutant strains exhibited growth that was indistinguishable
from the corresponding wild-type strain. This ﬁnding is
consistent with other studies showing that the amino
acid substitutions G135R, K136A-T137A and D161A in
yeast Clp1 did not affect viability (29,31). This result was
surprising given the conservation of these residues and
previous reports that similar active site substitutions in
known ATPases abolish ATP hydrolase activity (45,46).
Similar replacements also interfere with the ability of T4
polynucleotide kinase, tRNA ligases, the Grc3 RNA
kinase recently implicated in termination of transcription
by RNA polymerase I, and hClp1 homologs to phosphor-
ylate RNA (30–32,47). To more rigorously test the
possible importance of ATP binding, we created three
additional substitutions in Clp1 (K136E, T137W and the
double mutant K136E/T137W). These mutations, by
substituting a positively charged amino acid for a nega-
tively charged one (K136E) and a small amino acid for a
bulky one (T137W) in the Walker A motif, were designed
to be more disruptive to the ATP-binding site than alanine
substitutions of the same residues. Unlike the previous
mutations, none of these could support cell growth in
the absence of wild-type Clp1 on 5-FOA medium
(Figure 5A). Western blot conﬁrmed that the observed
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defects in mRNA 30-end formation and transcription termination
in vivo.( A) In vivo 30-end processing and termination assay. Quantitative
measurements of b-galactosidase activity were performed using wild-type
or mutant strains transformed with reporter vectors lacking or contain-
ing an efﬁcient polyadenylation signal upstream of the lacZ gene and
grown at 30 C. The amount of read-through is expressed as a percentage
of that obtained from vector lacking the poly(A) site. The data is the
average of 48 independent assays for each strain. The numbers under the
graph indicate the fold increase in read-through transcription over
the wild-type value for each poly(A) site. (B) Schematic depiction of
the PMA1 gene showing the position of its promoter (black box) and
two polyadenylation sites (vertical arrows). The regions probed by ChIP
are denoted 1–9. (C) Chromatin immunoprecipitation analysis of Rpb3
crosslinking to PMA1. Cells are grown at 30 C and then shifted to either
30 Co r3 9  C for an additional 60min. before formaldehyde
crosslinking. Lane C denotes a non-transcribed region of chromosome
V that serves as an internal background control. All PCR primer pairs
used in this analysis are identical to those described previously (41).
The input signal represents DNA prior to immunoprecipitation.
(D) Quantiﬁcation of the data shown in panel B. Rpb3 occupancy of
each of the indicated regions of PMA1 was calculated as a sample
IP:input ratio, normalized to the IP:input ratio of the untranscribed
region of chromosome V (lane C in RPB3 and INPUT panels) and
plotted as fold increase over background (ratio=1.0).
1220 Nucleic Acids Research, 2012,Vol.40, No. 3growth phenotypes were not due to instability of the
mutant proteins, as the steady-state protein levels were
comparable to wild-type (Figure 5B). In addition,
circular dichroism analysis indicated that the K136E/
T137W mutant had similar secondary structure as
wild-type Clp1 (data not shown). The inviability indicates
that the K136E and T137W substitutions in Clp1, which
are predicted to displace ATP, interfere with one or more
important functions of S. cerevisiae Clp1 in vivo.
ATP-binding assays were carried out to test whether
the Clp1 double mutant (K136E, T137W) impaired ATP
binding. When applied to a g-ATP-Agarose resin column,
both the wild-type and mutant proteins bound poorly,
suggesting that exchange with free ATP might be very
slow (data not shown). As an alternate approach, the
amount of ATP bound to wild-type and mutant protein
was assessed by reverse phase high-performance liquid
chromatography (HPLC) analysis using recombinant
protein, as described by Noble et al. (28). Similar
amounts of ATP were extracted from the wild-type and
mutant proteins (Figure 5C). This result shows that the
ATP-binding capacity of the K136E, T137W protein is
intact and that the inviability of the mutant is probably
not due to loss of ATP binding.
To determine what might be defective about a clp1
mutant with K136E and T137W replacements, we
examined the interaction with Pcf11 by two-hybrid
analysis (Figure 6A). The single mutations caused a
noticeably weaker interaction with Pcf11, and the inter-
action with the double mutant was signiﬁcantly worse. To
conﬁrm the loss of interaction observed by two-hybrid
analysis, we performed co-immunoprecipitations from
yeast extracts. As expected, the clp1 (K136E, T137W)
mutant protein is defective for Pcf11 interaction in com-
parison to wt Clp1 (Figure 6B). These results suggest that
how ATP sits in its Clp1-binding site affects speciﬁc inter-
actions on the Clp1 surface.
DISCUSSION
The polyadenylation of mRNA 30-ends in eukaryotes
requires a surprisingly large complex, which in yeast is
composed of four separate, but interacting factors,
namely, CF IA, CPF, Hrp1 and Pab1 (1,2) (Figure 7A).
All but two of the 21 individual subunits are essential. A
challenge in the ﬁeld has been to assign functions to these
numerous proteins and to understand how the arrange-
ment of proteins within the multisubunit CPF and CF
IA contributes to the activity of each factor. Several
subunits have enzymatic activities, such as the nuclease
Ysh1, the poly(A) polymerase Pap1, and two phosphat-
ases (Ssu72 and Glc7). Some subunits contact processing
signals on the RNA precursor, while others, such as Pta1,
Cft1, Pcf11 and Rna14, are thought to have scaffold func-
tions in organizing the complex and in physically coupling
processing to transcription and export (17,22,48–50). In
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Figure 5. Analysis of mutations in the ATP-binding site of Clp1. (A) Mutations predicted to displace ATP cause inviability. The XH5
[YCpURA3-CLP1] plasmid shufﬂe strains expressing V5-tagged versions of wild-type Clp1 or the indicated mutants (K136E, T137W and K136E/
T137W) were grown in selective medium, and 10-fold serial dilutions were spotted on 5-FOA plates and incubated for 4 days at 24 C. (B) In vivo
expression of clp1 mutants. Extracts from strains expressing either wild-type Clp1 or the indicated mutants were analyzed by western blot using
monoclonal antibody against the V5 tag or the CPF subunit Pta1 as a loading control. (C) Wild-type Clp1 and the clp1 (K136E,T137W) mutant
proteins contain equivalent amounts of ATP. Equal amounts of wild-type and mutant recombinant proteins were TCA precipitated and the
supernatant applied to a DNA Pac PA-100 (Dionex) HPLC column. Elution proﬁles were recorded at 260nm for ATP alone and for ATP extracted
from the acid-precipitated Clp1 mutant (red) and wild-type protein (green). ATP (blue) eluted at 0.57M NaCl on a gradient of 0–1M NaCl over
30min. For clarity, the three traces were displaced with respect to one another on the Y-axis.
Nucleic Acids Research,2012, Vol.40, No. 3 1221this study, we further our understanding of the role of the
Clp1 subunit of CF IA in the organization and activity of
the eukaryotic polyadenylation complex and discuss the
implications of our ﬁndings below.
Cross-factor contacts
Processing of mRNA 30-ends is initiated when the factors
that comprise the cleavage–polyadenylation complex rec-
ognize the constellation of signal sequences that surround
the poly(A) site. Cleavage removes at least one of these
signals, yet the complex must remain in stable association
with the RNA so that poly(A) addition is efﬁcient. Most
of the yeast and mammalian factors do not have strong
afﬁnity for their cognate sequences, and assembly of the
active complex is facilitated by cross-factor interactions.
The possible proteins mediating inter-factor contacts have
been most extensively investigated in the yeast system
(Figure 7A). For example, the Rna14 subunit of CF IA
can bridge to Hrp1 and also to CPF through association
with Fip1, Pfs2 and Cft1 (22,48,51,52). Pcf11 can associate
with Cft1, Cft2, Ysh1 and Pta1 (17,19) and contacts
between Rna15 and Hrp1 are induced when both
proteins bind RNA (23). It is important to note that
evidence for these interactions comes from in vitro
assays using individual subunits, and none of the
contacts have been conﬁrmed to occur in an assembled
processing complex.
In this study, we show that Clp1 can directly interact
with the Pfs2 and Ssu72 subunits of CPF, in addition
to the previously reported contacts with Cft1, Pta1 and
Ysh1 (17,19), and does so through different domains
(Figure 7B). However, Clp1 does not interact with Yth1,
Mpe1, Pap1, Cft2 and Fip1. hClp1, a subunit of the mam-
malian CF IIm factor, interacts with CF Im and CPSF
(53), and the Arabidopsis counterpart also interacts with
CPSF (54,55). CPSF contains homologs of Cft1, Cft2,
Fip1, Ysh1 and Yth1. Together, these ﬁndings support
the idea that one of the conserved functions of Clp1 is
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Figure 7. Regions and interactions of the yeast Clp1. (A) Summary of
physical interactions known to occur between subunits of CF IA and
other factors, indicated by connecting lines (Clp1 interactions, dashed
line; Pcf11 interactions, solid black line; Rna14 interactions, dotted line;
Rna15 interactions, gray line). These interactions include CPF subunits
(19,51,52), and this study), Hrp1 (26), Pab1 (11), the CTD of the Rpb1
subunit of RNA Polymerase II (RNAP II) (20,21), and Yra1 of the
mRNA export machinery (49). CPF subunits are indicated as rect-
angles; interactions of CF IA with CPF subunits in the right column
have not been demonstrated. (B) Schematic diagram of Clp1
summarizing the regions needed for interaction with different CPF
subunits. Pcf11 interacts with amino acids primarily in the central
domain of Clp1 but partly in the CTD (28). (C) Model of the Clp1
ATP-binding site, based on the published structure (28). The locations
of K136 and T137 are indicated. Parts of the surface composed of
carbon are colored green, oxygen is red, and nitrogen is blue.
Figure 6. Clp1 proteins with K136E and T137W replacements are de-
fective for Pcf11 interaction. (A) Two-hybrid analysis of the interaction
between Pcf11 and different forms of Clp1. Two-hybrid analysis was
performed as described in Figure 2C. (B) Pulldowns of Pcf11–Clp1
complexes in yeast extract. Extract was prepared from cells expressing
V5-tagged forms of either Clp1 or clp1 (K136E, T137W) in addition to
the untagged wt Clp1 needed for growth of the clp1(K136E, T137W)
strain. Cells were grown at 30 C. Immunoprecipitations from each
extract were conducted using antibody against the V5 epitope, and
blots of the precipitated proteins (IP) probed with Pcf11 or Clp1
antibody. The amount of Pcf11 in the different extracts is shown in
the panel marked ‘Input’.
1222 Nucleic Acids Research, 2012,Vol.40, No. 3to bridge different subcomplexes of the processing ma-
chinery. Interestingly, hClp1 cannot replace yeast Clp1
in vivo and unlike the yeast Clp1, is only needed for the
cleavage step and not for poly(A) addition (31,53), sug-
gesting important differences may exist in the protein
interaction networks of these two homologs.
Consistent with the idea that the processing complex
assembles on precursor RNA and then disassembles into
individual factors once poly(A) addition is complete, none
of the interactions of Clp1 with CPF subunits are as
strong as its interaction with Pcf11, a contact conserved
in the mammalian apparatus. The Pcf11-binding site is
located in a groove that is partly on the surface of the
central domain of Clp1 and partly at the interface of the
central domain and the CTD (28). Our site-directed mu-
tagenesis (Figure 2C) shows that this conserved inter-
action interface is indeed important for association of
these two CF IA subunits, and that disruption of this
contact interferes with CF IA function in mRNA 30-end
processing and transcription termination downstream of
poly(A) sites (Figures 3 and 4). These ﬁndings are com-
plementary to a concurrent study by Haddad et al. (R.
Haddad, F. Maurice, N. Viphakone, F. Voisinet-Hakil,
S. Fribourg and L. Minvielle-Se ´ bastia, in press), who
showed that mutations in Clp1 that disrupt Pcf11 inter-
action are similarly defective for cleavage and poly(A)
addition. Moreover, they found that depletion of Clp1 is
detrimental to sn/snoRNA termination. This loss of Clp1
did not perturb the levels of Pcf11, Rna14 and Rna15,
suggesting that Clp1, like the other CF IA subunits, also
has an important role in termination of non-adenylated
RNAP II transcripts.
Function of the ATP-binding site of yeast Clp1
Clp1 has been an intriguing component of the 30-end pro-
cessing complex because it contains a Walker A motif
characteristic of the P-loop found in ATP or
GTP-binding proteins, but no other motifs suggestive of
function. Determination of the structure of Clp1 showed
that it does indeed bind ATP (28), and the mammalian
homolog was found to provide RNA kinase activity
needed for one of the tRNA splicing pathways and for
activating synthetic siRNAs for incorporation into
silencing complexes (31,32). The alternate mechanism of
tRNA exon ligation thought to use hClp1 does not occur
in S. cerevisiae, and mutations in the ATP pocket that
should destroy this activity had no effect on Clp1
function in yeast (31) and this study). Noble et al. (28)
found that ATP hydrolysis by Clp1 was not activated by
the other CF IA subunits, and proposed that the contacts
of Clp1 with CPF might trigger nucleotide hydrolysis as
well as exposure of the ATP-binding site to allow for ADP
dissociation and ATP rebinding. Still, one would expect
that the mutations in conserved P-loop residues would
have growth defects if enzymatic activity was important
for the essential process of mRNA polyadenylation.
In this study, we discovered that more disruptive muta-
tions (K136E, T137W) in the P-loop of Clp1 were lethal,
but did not result in loss of ATP binding (Figure 5). In an
effort to explain this surprising result, we modeled the 3D
structure of the K136E, T137W mutant. The modeling
conﬁrmed that the mutated residues should interfere
with the ATP conformation observed in the crystal struc-
ture. We also noticed that the ATP-binding site in
wild-type Clp1 is signiﬁcantly larger than necessary
(Figure 7C). It is larger on both base and gamma phos-
phate ends of the nucleotide, and has an additional empty
space extending away from the ribose. In addition, the
phosphate-binding pocket appears both looser and less
basic than is common. Surprisingly, the extra space
around the phosphates is not ﬁlled with water molecules.
Whereas yeast Clp1 appears to be a catalytically dead
molecule, the mammalian homolog is an active kinase
that phosphorylates the 50-OH of RNA (31,32). Thus
the extra space near the ATP-binding site may be a
vestige of the RNA-binding site that is likely present in
active homologs of yeast Clp1. However, with only 24%
identity between the yeast and human proteins, further
meaningful comparison will require a structure of hClp1.
We have also not detected any interaction of Clp1 and
RNA by UV crosslinking (22) or by non-denaturing gel
electrophoresis (data not shown).
The ATP-binding cavity of Clp1 most closely resembles
that of two characterized ATPases: the NifH Fe subunit of
the Azobabactr vinelandii nitrogenase and the E. coli de-
toxiﬁcation pump protein ArsA (28). ATP hydrolysis by
these enzymes transmits conformational changes in the
macromolecular complexes in which NifH and ArsA
reside. Our analysis of the K136E, T137W mutant
suggests that Clp1 may function in a similar way, but
one that does not require catalysis. Our data show that
the contact with Pcf11 was dramatically weakened
(Figure 6), even though the ATP-binding site is well
removed from the binding site of Pcf11 (28). This
mutation does not abrogate nucleotide binding
(Figure 5), suggesting a speciﬁc change in the conform-
ation of the protein rather than gross misfolding of the
central domain. Interestingly, Haddad et al. (29) have
shown that nonlethal mutations in the P-loop domain of
Clp1 will impair 30-end processing if they are paired with a
mutation in the Pcf11-binding region. This combination of
mutations not only disrupts the binding of Pcf11 to Clp1,
and but also its binding to the Rna14–Rna15 subcomplex,
suggesting that the Clp1–Pcf11 interaction is modulated
by how Clp1 binds ATP, which in turn causes a conform-
ational change in Pcf11 that promotes its interaction with
Rna14–Rna15.
One interpretation of these observations is that the
ATP-binding site of Clp1 functions as a molecular
switch in which the mode of ATP binding induces con-
formational changes necessary for processing activity. A
repositioning of the ATP mimicked by the K136E, T137W
mutations could occur naturally by opening of the lid
formed by the N-terminal domain, which on its inner
surface makes contact with the adenine base and 20 OH
of the ribose (28). Ssu72 and the endonuclease Ysh1, two
subunits of CPF essential for the cleavage step, interact
with the N-terminal domain and could mediate such a
repositioning, which in turn would loosen the interaction
with Pcf11. It is not clear how these changes might help
the complex move through a cycle of processing, but our
Nucleic Acids Research,2012, Vol.40, No. 3 1223ﬁndings with the pcf11(RW-A) mutant (Figures 3 and 4)
show that weakening the association of Clp1 and Pcf11
affects cleavage, poly(A) addition and termination down-
stream of poly(A) sites. In the lethal K136E, T137W
mutant, we would predict that processing would be
blocked at some point because the reorientation of the
ATP is not reversible.
It is also interesting to note that Pcf11 is not an obliga-
tory partner for Clp1. hPcf11, while binding Clp1 in the
mRNA cleavage factor CF IIm, is not found with Clp1 in
the human tRNA splicing endonuclease complex (32,53).
Furthermore, the Clp1 interaction region on Pcf11
overlaps with that of the mRNA export factor Yra1
(49), and it has been proposed that Clp1 exchanges with
Yra1 in a transition that leads to 30-end processing and
mRNP maturation when the transcription elongation
complex reaches the end of a gene. While it is conceivable
that the two proteins can bind Pcf11 simultaneously, the
ATP binding of Clp1 could also have a role in switching
Pcf11 partners. Consistent with this possibility, the Clp1–
Pcf11 interaction is important in recruiting Rna15 to
the RNAP II elongation complex (29).
In summary, our ﬁndings support a model in which
Clp1 has a dynamic structural role in the assembly of
the mRNA cleavage–polyadenylation complex on the
poly(A) site and subsequent processing at that site.
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